BPIQ Blog

Biopharma Mid Morning Pulse - 07/26/22

(Posted 10:05am CST) $XBI $80.41 | -0.65% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Free Biopharma Mid Morning Pulse - 07/26/22

(Posted 10:05am CST) $XBI $80.41 | -0.65% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Biopharma Pulse - 6/27-7/1 Week in Review

As we reach the end of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...

Biopharma Daily Stock Updates - 06/29/22

$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...

Free Biopharma Daily Stock Updates - 06/29/22

$XBI $74.80 | +1.0% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +1.6% Novavax COVID-19 Data...

Biopharma Daily Stock Updates - 06/27/22

$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...

Free Biopharma Daily Stock Updates - 06/27/22

$XBI $76.80 | -0.34% Table of Contents: Pipeline Updates Business Updates Covid Updates #BNTX +7.2% Pfizer and BioNTech Announce...

Biopharma Pulse - 6/20-6/24 Week in Review

As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...

Biopharma Pulse - 2/28-3/4 Week in Review

As we have reached the end of February, we review moves from smid-cap biopharma companies during this past week as well as for the month...

J.P. Morgan Healthcare Conference

The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...

COVID-19 Therapeutic Stocks to Watch (June 2021)

Summary Over 40 Smid-Cap companies currently have active trials involving COVID therapeutics (this includes small molecules and...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity